期刊
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
卷 41, 期 1, 页码 26-33出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biocel.2008.05.028
关键词
HIC1; 17p13.3; Transcriptional repression; P53; SIRT1
资金
- Ministere de l'Education Nationale et de la Recherche
- CNRS/Region Nord-Pas de Calais
- Association for International Cancer Research (AICR)
- CNRS
- PASTEUR Institute of Lille
- Ligue contre le Cancer
- ARC [3983]
- NINDS, NIH
- [1K08NS051477]
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051477] Funding Source: NIH RePORTER
HIC1 (Hypermethylated in Cancer 1). as it name implied, was originally isolated as a new candidate tumor supressor gene located at 17p13.3 because it resides in a CpG island that is hypermethylated in many types of human cancers. HIC1 encodes a transcription factor associating an N-terminal BTB/POZ to five C-terminal Kruppel-like C2H2 zinc finger motifs. In this review,we will begin by providing an overview of the current knowledge on HIC1 function, mainly gained from in vitro studies, as in sequence-specific transcriptional repressor interacting with a still growing range of HDAC-dependent and HDAC-independent corepressor complexes. We will then Summarize the studies that have demonstrated frequent hypermethylation changes or losses of heterozygosity of the HIC1 locus it human cancers. Next, we will review animal models which have firmly established HIC1 as a bonafide tumor Suppressor gene epigenetically silenced and functionally cooperating g notably with p53 within a complex HIC1-p53-SIRT1 regulatory loop. Finally, we will discuss how this epigenetic inactivation of HIC1 might addict cancer cells to altered survival and signaling pathways or to lineage-specific transcription factors during the early Stages Of tumorigenesis. (C) 2008 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据